A look at the companies seeing significant price changes in midday trading, including Hims & Hers, Vertex Pharmaceuticals, Palantir Technologies, Darden Restaurants, Accenture, and Micron Technology.
Hims & Hers shares dropped over 10% as the FDA declared the active ingredient in weight loss drugs Mounjaro and Zepbound is no longer in shortage. The company provides access to GLP-1 injections. Vertex Pharmaceuticals fell around 13% after announcing Phase 2 study results for suzetrigine, a pain signal inhibitor. While placebo recipients showed similar pain reduction, the company plans to proceed with Phase 3 trials. Palantir Technologies rose 4% following an extended partnership with the U.S.
Army, valued at $400.7 million for up to four years with a potential ceiling of $618.9 million. Darden Restaurants surged over 15% on better-than-expected same-store sales growth at Olive Garden and LongHorn Steakhouse. The company also increased its full-year revenue guidance to $12.1 billion. Accenture gained about 7% after exceeding fiscal first-quarter revenue expectations and raising its full-year guidance to 4% to 7% revenue growth. Finally, Micron Technology plummeted over 16% due to weaker-than-expected fiscal second-quarter guidance, attributed to weaker consumer-oriented markets. CEO Sanjay Mehrotra expects a return to growth in the second half of the fiscal year
STOCK MARKET COMPANY PERFORMANCE HEALTHCARE TECHNOLOGY RESTAURANTS
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Morgan Stanley Sees 53% Upside in Hims & Hers StockAnalyst Craig Hettenbach initiated coverage of Hims & Hers Health with an overweight rating and $42 price target, citing strong growth prospects in mental health, weight loss, and dermatology treatments.
Read more »
Charts indicate this health-care stock could eventually double, according to Todd GordonThe chart analyst and investor breaks down the chart in Hims & Hers Health.
Read more »
Wall Street is turning bullish on this biotech. How to play it with optionsNishant Pant breaks down a bull call spread trade in Vertex Pharmaceuticals.
Read more »
Top 2025 Biotech Stocks to Watch Beyond Vaccine MakersStocks Analysis by MarketBeat.com (Nathan Reiff) covering: Eli Lilly and Company, Pfizer Inc, AstraZeneca PLC ADR, Hims Hers Health Inc. Read MarketBeat.com (Nathan Reiff)'s latest article on Investing.com
Read more »
Amazon Stock Eyes Growth With Bold Healthcare ExpansionStocks Analysis by MarketBeat.com (Jeffrey Neal Johnson) covering: Amazon.com Inc, Pharmocann Global Ltd, Hims Hers Health Inc. Read MarketBeat.com (Jeffrey Neal Johnson)'s latest article on Investing.com
Read more »
Here are Thursday's biggest analyst calls: Nvidia, Apple, Coca-Cola, McDonald's, Palantir & moreHere are Thursday's biggest calls on Wall Street.
Read more »